SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-17-002631
Filing Date
2017-05-11
Accepted
2017-05-11 16:14:20
Documents
4
Period of Report
2017-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_051117.htm 8-K 21622
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 27533
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 13842
4 GRAPHIC ohr8k001.jpg GRAPHIC 4553
  Complete submission text file 0001387131-17-002631.txt   70750
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 17834445
SIC: 2834 Pharmaceutical Preparations